PMV Pharmaceuticals, Inc.
Our corporate headquarters is in Cranbury, New Jersey.
PMV Pharma was incorporated in 2013.
PMV Pharma went public on September 25, 2020.
PMV Pharma is traded on the NASDAQ Global Select Market with the stock symbol PMVP.
December 31st.
PMV Pharma does not anticipate issuing dividends on its stock in the foreseeable future.
PMV Pharma’s independent auditors are Ernst & Young LLP.
PMV Pharma’s outside legal counsel is Wilson Sonsini Goodrich & Rosati.
Please visit www.pmvpharma.com or email investors@pmvpharma.com.
Our SEC filings are listed on the SEC’s website, www.sec.gov. You may find this information on our investor relations website at www.pmvpharma.com, under ‘financials and filings’.
PMV Pharma's transfer agent is American Stock Transfer & Trust Company, LLC (AST).
PMV Pharma’s CUSIP number is 69353Y 103.